Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Zimmer Holdings (NY:ZBH)

91.46 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Peering Into Zimmer Biomet Holdings's Recent Short Interest
Via Benzinga
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - An Undervalued Stock Worth Considering
ZIMMER BIOMET (NYSE:ZBH) is an undervalued medical device stock with strong profitability, a reasonable dividend, and improving growth prospects. A solid pick for value investors. 
Via Chartmill
3 Out-of-Favor Stocks with Questionable Fundamentals
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
2 Mid-Cap Stocks to Consider Right Now and 1 to Question
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
Via StockStory
How Is The Market Feeling About Zimmer Biomet Holdings?
Via Benzinga
Earnings Scheduled For May 5, 2025
Via Benzinga
A Glimpse of Zimmer Biomet Holdings's Earnings Potential
Via Benzinga
Zimmer Biomet Holdings Inc (NYSE:ZBH) - A Reliable Dividend Stock Worth Considering
Zimmer Biomet Holdings (NYSE:ZBH) offers a reliable dividend with strong profitability and reasonable valuation, making it a solid pick for income investors. 
Via Chartmill
3 S&P 500 Stocks Facing Headwinds
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - An Undervalued Stock With Solid Fundamentals
ZIMMER BIOMET HOLDINGS (NYSE:ZBH) is an undervalued medical device stock with strong profitability, reasonable debt, and improving growth prospects, making it a candidate for value investors. 
Via Chartmill
A Look Back at Surgical Equipment & Consumables - Diversified Stocks’ Q1 Earnings: Zimmer Biomet (NYSE:ZBH) Vs The Rest Of The Pack
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Zimmer Biomet Holdings Inc (NYSE:ZBH) - A Reliable Dividend Stock Worth Considering
Zimmer Biomet Holdings (NYSE:ZBH) offers a reliable dividend with strong profitability and decent financial health, making it a candidate for income investors. 
Via Chartmill
Gapping S&P500 stocks in Monday's session
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
ZBH Q1 Earnings Call: Revenue Tops Expectations, Guidance Lowered Amid Tariff and Integration Headwinds
Medical device company Zimmer Biomet (NYSE:ZBH) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per... 
Via StockStory
Topics Economy World Trade
Assessing Zimmer Biomet Holdings: Insights From 10 Financial Analysts
Via Benzinga
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
ZIMMER BIOMET HOLDINGS INC has a stellar value proposition. NYSE:ZBH not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. 
Via Chartmill
These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results
Via Benzinga
Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal
Zimmer Biomet Q1 sales rose 1.1% to $1.91 billion; FY25 EPS outlook trimmed but revenue growth forecast lifted following Paragon 28 acquisition. 
Via Benzinga
What's going on in today's session: S&P500 movers
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Monday. 
Via Chartmill
Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday?
Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services... 
Via Benzinga
Why Zimmer Biomet (ZBH) Stock Is Trading Lower Today
Shares of medical device company Zimmer Biomet (NYSE:ZBH) fell 10.2% in the afternoon session after the company reported underwhelming first quarter 2025 results as it lowered its full-year EPS... 
Via StockStory
Topics Artificial Intelligence
These S&P500 stocks have an unusual volume in today's session
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below. 
Via Chartmill
Services Activity Barely Expands In April As Price Pressures Spike To Over 2-Year Highs: 'A Worrying Backstory Is Developing'
US services sector growth slows in April. Inflationary pressures surge to a 2-year high, driven by trade tariffs. Stalling momentum and stagflation risks loom. 
Via Benzinga
Topics Economy World Trade
Which S&P500 stocks are moving on Monday?
Stay updated with the movements of the S&P500 index in the middle of the day on Monday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
Zimmer Biomet Stock Plummets On 2025 Earnings Outlook Downgrade: But Retail’s Bullish
Zimmer now expects 2025 adjusted profit per share in the range of $7.90 to $8.10, compared with its prior forecast of $8.15 to $8.35 per share. 
Via Stocktwits
Topics World Trade
Gapping S&P500 stocks in Monday's session
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
Zimmer Biomet (NYSE:ZBH) Posts Better-Than-Expected Sales In Q1
Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q1 CY2025, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per share was 2.3%... 
Via StockStory
Zimmer Biomet (ZBH) Reports Q1: Everything You Need To Know Ahead Of Earnings
Medical device company Zimmer Biomet (NYSE:ZBH) will be announcing earnings results tomorrow before market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
1 Value Stock Worth Investigating and 2 to Brush Off
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.